Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lipidor updates on Phase III study of AKP02 in treatment of psoriasis - half of patients now recruited 2022-05-20 14:56
Animal health company Emollivet raises capital and strengthens team 2022-03-15 15:48
Emollivet launches spray for equestrian pastern dermatitis 2022-03-03 17:07
Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis 2022-01-26 21:57
Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris 2021-12-17 16:10
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis 2021-09-27 17:37
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70 2021-07-02 05:32
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova 2021-04-23 15:22
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis 2021-04-22 16:02
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production 2020-12-16 16:12
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis 2020-07-08 14:57
Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB Through License Agreement and Proposes Financing of Subsidiary 2020-07-01 08:06
New Disinfection Spray From Lipidor and Aurena Laboratories 2020-03-04 15:20
Lipidor Announces Positive Topline Results of AKP01 Phase III Clinical Study Using Calcipotriol Spray Against Psoriasis 2020-01-24 23:21
Lipidor Announces Enrolment of Last Patient in Calcipotriol/AKVANO Spray (AKP01) Phase III Study Targeting Psoriasis 2019-09-09 20:37
1